ENDV
NDONOVO THERAPEUTICS INC
stockOTC
endonovo therapeutics (otcqb: endv) is an innovative biotechnology company developing a bioelectronic approach to regenerative medicine. endonovo's immunotronics™ platform is a non-invasive, non-implantable bioelectronic device for treating/preventing vital organ failure through the reduction of inflammation and necrosis, and the promotion of regeneration. endonovo's cytotronics™ platform provides for a method of expanding and manipulating cells using simulated microgravity and time-varying electromagnetic fields (tvemf) for tissue engineering and cell therapies.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 0.00 | 2026-09-30 | -50.00% | 0.000 |
| 1M | 0.00 | 2026-09-03 | -50.00% | -1678.653 |
| 3M | 0.00 | 2026-07-06 | -50.00% | -435.939 |
| 6M | 0.00 | 2026-04-06 | -50.00% | -57.295 |
| 1Y | 0.00 | 2025-10-06 | -50.00% | 83.156 |
| 2Y | 0.00 | 2024-10-07 | -94.44% | — |
| 5Y | 0.03 | 2021-10-05 | -99.81% | 18.732 |
NDONOVO THERAPEUTICS INC (OTC:ENDV) stock price today is $0.00, and today's volume is 500,000. ENDV is down 50.000% today. The 30 day average volume is 714,318. ENDV market cap is $19,841 with 396.83M shares outstanding.